Aoxin Q & M Anticipates Rebound in H1 2024
Aoxin Q & M Anticipates Rebound in H1 2024
In the preceding half year, the company narrowed its net loss to $210,000 (CNY1.15m).The company reported a net loss of $210m in H1 2023.
公司在2023年上半年报告了21000万元的净亏损。
Aoxin Q & M Dental Group said it anticipates its January to June (H1 2024) net earnings to improve on a year-on-year basis, compared to the net loss recorded last year.
Aoxin Q&M牙科集团表示，预计其2024年1月至6月（2024年上半年）净利润将与去年同期相比有所改善，与去年记录的净亏损相比。
The rebound is heavily influenced by "the increase in revenue generated from primary healthcare and laboratory services as well as a general reduction in expenses."
复苏受到“初级医疗保健和实验室服务收入增长以及一般支出减少”的影响。
In the preceding half year, the company narrowed its net loss to $210,000 (CNY1.15m).
在前一半年，公司将净亏损缩小至210,000美元（人民币1.15万元）。
The profit guidance follows a preliminary review of the company's unaudited financial results for H1 2024. Full details will be disclosed on or before 14 August.
利润指导基于公司2024年上半年未经审计的财务结果的初步审查。完整细节将在8月14日或之前披露。
($1.00 = CNY5.41)
（1.00美元=5.41人民币）
译文内容由第三方软件翻译。
